Virus-host interactions encompass the complex relationship between viruses and their host organisms. These interactions are critical determinants of the outcome of viral infections, influencing factors such as host susceptibility, immune response, and the severity of disease. Upon entering a host, viruses interact with specific host cell receptors, facilitating attachment and entry. The host immune system recognizes and responds to viral infections through intricate signaling pathways, involving the activation of various immune cells and the release of antiviral molecules. Viruses, in turn, employ diverse strategies to evade or modulate host immune responses. This includes the inhibition of host antiviral proteins, interference with cellular signaling, and the ability to establish latent infections. Understanding virus-host interactions is essential for developing therapeutic interventions. Research in this field aims to uncover the molecular mechanisms governing these interactions, identify potential targets for antiviral drugs, and design strategies to modulate host immune responses for better outcomes. Ongoing studies in virology continue to deepen our understanding of virus-host interactions, contributing to the development of effective treatments and vaccines against viral infections.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India